PreveCeutical Medical Inc Market Cap ($3.34 Million)
Market Cap & Net Worth: PreveCeutical Medical Inc (18H)
PreveCeutical Medical Inc market cap. PreveCeutical Medical Inc (F:18H) has a market capitalization of $3.34 Million (€2.85 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #29295 globally and #2536 in its home market, demonstrating a -77.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PreveCeutical Medical Inc's stock price €0.01 by its total outstanding shares 570649459 (570.65 Million). Also see PreveCeutical Medical Inc cash flow conversion for how efficiently the company converts equity into cash flow.
PreveCeutical Medical Inc Market Cap History (2017–2026)
PreveCeutical Medical Inc market cap history from 2017 to 2026. Data shows change from $40.43 Million to $3.34 Million (-28.82% CAGR). Check current stock price of PreveCeutical Medical Inc for real-time trading data and today's change.
PreveCeutical Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PreveCeutical Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of PreveCeutical Medical Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
330.16x
PreveCeutical Medical Inc's market cap is 330.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $40.43 Million | $22.23K | -$7.23 Million | 1818.35x | N/A |
| 2018 | $10.67 Million | $15.45K | -$11.88 Million | 690.81x | N/A |
| 2019 | $1.00 Million | $3.03K | -$3.58 Million | 330.16x | N/A |
Competitor Companies of 18H by Market Capitalization
Companies near PreveCeutical Medical Inc in the global market cap rankings as of November 1, 2026. Also see 18H current and non-current assets for a full breakdown of the balance sheet.
Key companies related to PreveCeutical Medical Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of PreveCeutical Medical Inc (2017–2026)
Market capitalization of PreveCeutical Medical Inc from 2017 to today. Between 2017 and today, PreveCeutical Medical Inc's market cap moved from $40.43 Million to $ 3.34 Million, with a yearly change of -28.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.34 Million | -54.55% |
| 2025 | €7.34 Million | -21.43% |
| 2024 | €9.34 Million | 0.00% |
| 2023 | €9.34 Million | -17.65% |
| 2022 | €11.34 Million | +70.00% |
| 2021 | €6.67 Million | -42.86% |
| 2020 | €11.68 Million | +1066.67% |
| 2019 | €1.00 Million | -90.62% |
| 2018 | €10.67 Million | -73.60% |
| 2017 | €40.43 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of PreveCeutical Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.34 Million USD |
| MoneyControl | $3.34 Million USD |
| MarketWatch | $3.34 Million USD |
| marketcap.company | $3.34 Million USD |
| Reuters | $3.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disor… Read more